Early response does not predict outcome in children and adolescents with chronic myeloid leukaemia treated with high-dose imatinib

Br J Haematol. 2018 Mar;180(6):895-898. doi: 10.1111/bjh.14458. Epub 2016 Dec 16.
No abstract available

Keywords: CML; childhood leukaemia; early response; outcome; tyrosine kinase inhibitors.

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Imatinib Mesylate / administration & dosage*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality*
  • Male

Substances

  • Imatinib Mesylate